From Bias to Balance: Rethinking Clinical Trial Site Strategy with AI

Clinical trials are the backbone of medical innovation, but far too often, they reinforce existing health inequities. Poor site selection, outdated assumptions, and limited visibility into real-world patient distribution lead to underrepresentation and missed opportunities.  InsightLaunch™ by UniqueMinds helps pharma teams leverage AI to synthesize patient data across geographies, demographics, and health systems, enabling faster, fairer, and more strategic trial site decisions. Built…

Turning Data Blind Spots into Regulatory and Commercial Advantage with Impact Lab™

The life sciences industry is awash in data — real-world evidence, claims, EMR, lab values, genomics, social determinants. But the challenge isn’t just access; it’s action. Hidden biases, misaligned metrics, and operational silos prevent that data from becoming trusted insight.  Impact Lab™ by UniqueMinds gives pharma organizations a safe, governed space to pilot, evaluate, and operationalize AI…